The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD
Biomed Pharmacother. 2021 Feb 6;135:111235. doi: 10.1016/j.biopha.2021.111235. Online ahead of print. PMID: 33561650 Review.
An increasing number of studies have revealed a close relationship between the intestinal microbiota and the development of NAFLD and ALD. A better understanding of the role of intestinal microbiota and the intestine-liver axis thus might lead to the d …
